Latest News - Cardiovascular News

Long term data presented at ESC 2010 further supports the benefit of the CYPHER sirolimus drug-eluting stent compared to the ENDEAVOR Zotarolimus-eluting stent in important high-risk subgroups.

Tue, 07 Sep 2010 11:56:00 +0000

Additional analysis of 18 month data of the SORT OUT III trial provides detail on safety and efficacy outcomes in patients with diabetes, acute coronary syndrome, or treatment of multiple lesions.

Cortisol levels in hair linked to heart attack risk

Mon, 06 Sep 2010 11:14:00 +0000

Cortisol levels in hair may be the first biomarker to measure chronic stress, which is linked to a higher risk of having a heart attack.

Highlight from ESC 2010: A SHIFT in heart failure treatment

Fri, 03 Sep 2010 12:58:00 +0000

Large-scale study shows positive results for drug ivabradine in reducing chronic heart failure; EINSTEIN-DVT also shows positive outcomes for rivaroxaban.

CORDIS announces results of ten-year CYPHER sirolimus-eluting coronary stent follow-up

Tue, 31 Aug 2010 14:59:00 +0000

Publication of decade follow-up test results on first CYPHER sirolimus-eluting coronary stent patient reveal the stent’s outstanding efficacy and safety.

New NICE guidance published to improve diagnosis and treatment of chronic heart failure

Thu, 26 Aug 2010 09:56:00 +0000

Update on chronic heart failure replaces July 2003 clinical guideline.